Aerogen, the Ireland-based global leader in acute-care aerosol drug delivery, has announced the opening of its India headquarters in the National Capital Territory of Delhi.
The new office was officially inaugurated by Ireland’s Minister for Higher Education, Research, and Innovation, James Lawless, during his visit to India on the occasion of Ireland’s National Day – St. Patrick’s Day, on March 17. This strategic expansion underscores Aerogen’s commitment to supporting India’s growing healthcare sector by improving access to cutting-edge aerosol drug delivery solutions.
With over 55 million people in India suffering from chronic obstructive pulmonary disease (COPD) and a significant burden of respiratory diseases, Aerogen’s innovative vibrating mesh nebuliser technology is set to play a transformative role in enhancing patient outcomes. Already the standard of care in Europe and the USA, Aerogen’s drug delivery system is now poised to support Indian healthcare providers in delivering high-quality respiratory care.
The opening of the India headquarters represents a major investment in the APAC region and reinforces Aerogen’s long-term vision for India. The new office in New Delhi will serve as the operational hub for a growing team of experts, including a country director, marketing professionals, commercial sales specialists, and clinical experts. Starting with 14 team members, Aerogen plans to expand to 30 employees over the next five years to support its growth and market penetration.
Designed to foster innovation and collaboration, the India headquarters features state-of-the-art meeting rooms, private offices, a reception area, a library, a gym and yoga space, a recreation zone, and a landscaped lawn, providing a dynamic and inspiring workspace for the team.
Aerogen’s India expansion is a reflection of the robust economic ties between Ireland and India. The company’s global growth has been supported by Enterprise Ireland, the Irish government agency that helps Irish businesses scale internationally.
Aerogen’s presence in India is set to drive investment in research, partnerships, and training programmes to ensure the widespread adoption of its advanced aerosol drug delivery technology. By collaborating with leading clinicians, hospitals, and channel partners across India and Sri Lanka, Aerogen is positioned to revolutionize respiratory care, ultimately improving patient outcomes and strengthening the country’s healthcare infrastructure.
